Vivos Therapeutics Has Received A Notice Of Allowance For Its U.S. Patent Application 17/522,740 Titled "Vibrational Oral Appliance With Mandibular Advancements (To Provide Relief From Sleep Disordered Breathing, Sleep Apnea And/Or Snoring)"
Portfolio Pulse from Benzinga Newsdesk
Vivos Therapeutics has received a notice of allowance for its U.S. patent application 17/522,740, titled 'Vibrational Oral Appliance with Mandibular Advancements,' aimed at providing relief from sleep disordered breathing, sleep apnea, and/or snoring. This development marks a significant milestone for the company in its efforts to innovate in the field of sleep disorder treatments.
April 04, 2024 | 3:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vivos Therapeutics' receipt of a notice of allowance for its patent application on a sleep disorder treatment device represents a significant advancement in its product offerings and could enhance its market position.
The receipt of a notice of allowance for a patent application is a critical step in securing intellectual property rights, which can protect and enhance the value of a company's innovations. For Vivos Therapeutics, this development not only bolsters its portfolio of treatment solutions for sleep disorders but also potentially sets it apart from competitors. This could lead to increased investor confidence and a positive impact on the company's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100